Conventional Versus Left Bundle Branch Pacing in TAVI
Primary Purpose
Aortic Valve Stenosis, Heart Failure, Pacemaker-Induced Cardiomyopathy
Status
Not yet recruiting
Phase
Not Applicable
Locations
Slovenia
Study Type
Interventional
Intervention
Left bundle branch pacemaker
Conventional pacing
Sponsored by
About this trial
This is an interventional treatment trial for Aortic Valve Stenosis focused on measuring Transcatheter Aortic Valve Implantation, Left bundle branch pacing
Eligibility Criteria
Inclusion Criteria: Indication for permanent pacemaker implantation after transcatheter aortic valve implantation (during the same hospitalization) Left ventricular ejection fraction < 50 %. Exclusion Criteria: Unsuccessful TAVI procedure with life expectancy < 1 year Ischemic cardiomyopathy with interventricular septal fibrosis (at least echocardiographic signs of fibrosis) Severe kidney failure (glomerular filtration rate < 30 ml/min) Previous permanent pacemaker
Sites / Locations
- University Medical Centre Ljubljana
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Conventional pacing
LBB pacing
Arm Description
Outcomes
Primary Outcome Measures
Left ventricular ejection fraction
Secondary Outcome Measures
Left ventricular systolic diameter
Left ventricular diastolic diameter
Global work index
Amount of myocardial work performed by the left ventricle during systole.
Global constructive work
Positive work performed in systole + negative work performed in isovolumetric relaxation
Global wasted work
Negative work performed in systole + positive work performed in isovolumetric relaxation
Global work efficiency
Percentage of constructive work over total work = Constructive work/(constructive work + wasted work)
Signs of mechanical dyssynchrony
Presence of at least one of the echocardiographic signs of mechanical dyssynchrony, such as apical rocking and septal flash.
Systolic pulmonary artery pressure (echocardiographic parameter)
NT-proBNP concentration
NYHA status
6-minute walking test
Hand grip test
The Kansas City Cardiomyopathy Questionnaire (KCCQ-12)
KCCQ scores are scaled from 0 to 100 and frequently summarized in 25-point ranges, where scores represent health status as follows: 0 to 24: very poor to poor; 25 to 49: poor to fair; 50 to 74: fair to good; and 75 to 100: good to excellent.
QRS duration
Full Information
NCT ID
NCT05895097
First Posted
February 6, 2023
Last Updated
June 5, 2023
Sponsor
University Medical Centre Ljubljana
1. Study Identification
Unique Protocol Identification Number
NCT05895097
Brief Title
Conventional Versus Left Bundle Branch Pacing in TAVI
Official Title
Impact of Conduction System Pacing on Left Ventricular Remodeling After Transcatheter Aortic Valve Implantation
Study Type
Interventional
2. Study Status
Record Verification Date
June 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
June 15, 2023 (Anticipated)
Primary Completion Date
June 15, 2025 (Anticipated)
Study Completion Date
June 15, 2026 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University Medical Centre Ljubljana
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This randomized study compares the effects of conventional (right ventricular pacing in patients with LVEF ≥ 40% and cardiac resynchronization therapy in patients with LVEF < 40 %) versus left bundle branch pacing on left ventricular remodelling in patients with reduced left ventricular ejection fraction (< 50 %) that need permanent pacemaker implantation after transcatheter aortic valve implantation (TAVI).
Detailed Description
Bradycardic heart rhythm disturbances are a common complication of TAVI. Patients who will develop the indication for permanent pacemaker implantation after TAVI will be randomly assigned to either the experimental (left bundle branch pacing) or conventional (right ventricular pacing in patients with LVEF ≥ 40% and cardiac resynchronization therapy in patients with LVEF < 40 %) group. The investigators will compare the left ventricular ejection fraction (primary outcome) 12 months after randomization. The investigators will also compare electrocardiographic (QRS duration), clinical (NYHA status, 6-minute walking test, handgrip test, Kansas City Cardiomyopathy Questionnaire) and laboratory (proBNP) parameters 6 and 12 months, and other echocardiographic (left ventricular systolic and diastolic diameter, signs of dyssynchrony, myocardial work) parameters 12 months after pacemaker implantation in both groups.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Aortic Valve Stenosis, Heart Failure, Pacemaker-Induced Cardiomyopathy, Transcatheter Aortic Valve Implantation
Keywords
Transcatheter Aortic Valve Implantation, Left bundle branch pacing
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
50 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Conventional pacing
Arm Type
Active Comparator
Arm Title
LBB pacing
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
Left bundle branch pacemaker
Intervention Description
Left bundle branch pacing (LBBP) will be the pacing technique. In brief, after localizing the His bundle area the LBBP lead will be positioned approximately 1-1.5 cm distal to the His bundle position in the right ventricular septum. Before screwing the lead deep into the interventricular septum, the suitable position will be confirmed by fluoroscopic signs and adequate paced QSR morphology. Final lead position will be confirmed according to ECG parameters. Given that the pacing parameters with LBBP are typically low and stable, backup RV lead will not be mandatory.
Intervention Type
Device
Intervention Name(s)
Conventional pacing
Intervention Description
Right ventricular pacing in patients with LVEF ≥ 40% and cardiac resynchronization therapy in patients with LVEF < 40 %
Primary Outcome Measure Information:
Title
Left ventricular ejection fraction
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Left ventricular systolic diameter
Time Frame
12 months
Title
Left ventricular diastolic diameter
Time Frame
12 months
Title
Global work index
Description
Amount of myocardial work performed by the left ventricle during systole.
Time Frame
12 months
Title
Global constructive work
Description
Positive work performed in systole + negative work performed in isovolumetric relaxation
Time Frame
12 months
Title
Global wasted work
Description
Negative work performed in systole + positive work performed in isovolumetric relaxation
Time Frame
12 months
Title
Global work efficiency
Description
Percentage of constructive work over total work = Constructive work/(constructive work + wasted work)
Time Frame
12 months
Title
Signs of mechanical dyssynchrony
Description
Presence of at least one of the echocardiographic signs of mechanical dyssynchrony, such as apical rocking and septal flash.
Time Frame
12 months
Title
Systolic pulmonary artery pressure (echocardiographic parameter)
Time Frame
12 months
Title
NT-proBNP concentration
Time Frame
6 and 12 months
Title
NYHA status
Time Frame
6 and 12 months
Title
6-minute walking test
Time Frame
6 and 12 months
Title
Hand grip test
Time Frame
6 and 12 months
Title
The Kansas City Cardiomyopathy Questionnaire (KCCQ-12)
Description
KCCQ scores are scaled from 0 to 100 and frequently summarized in 25-point ranges, where scores represent health status as follows: 0 to 24: very poor to poor; 25 to 49: poor to fair; 50 to 74: fair to good; and 75 to 100: good to excellent.
Time Frame
6 and 12 months
Title
QRS duration
Time Frame
baseline, 6, and 12 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Indication for permanent pacemaker implantation after transcatheter aortic valve implantation (during the same hospitalization)
Left ventricular ejection fraction < 50 %.
Exclusion Criteria:
Unsuccessful TAVI procedure with life expectancy < 1 year
Ischemic cardiomyopathy with interventricular septal fibrosis (at least echocardiographic signs of fibrosis)
Severe kidney failure (glomerular filtration rate < 30 ml/min)
Previous permanent pacemaker
Facility Information:
Facility Name
University Medical Centre Ljubljana
City
Ljubljana
ZIP/Postal Code
1000
Country
Slovenia
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Klemen Steblovnik, MD, PhD
Phone
0038615228529
Email
steblovnik@gmail.com
First Name & Middle Initial & Last Name & Degree
Klemen Steblovnik, MD, PhD
First Name & Middle Initial & Last Name & Degree
David Zizek, MD, PhD
First Name & Middle Initial & Last Name & Degree
Matjaz Bunc, MD, PhD
First Name & Middle Initial & Last Name & Degree
Peter Marko Mihailovic, MD, PhD
First Name & Middle Initial & Last Name & Degree
Simon Terseglav, MD
First Name & Middle Initial & Last Name & Degree
Ana Kovac, MD, PhD
First Name & Middle Initial & Last Name & Degree
Anja Zupan Meznar, MD, PhD
First Name & Middle Initial & Last Name & Degree
Ljupka Dimitrovska, MD
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Conventional Versus Left Bundle Branch Pacing in TAVI
We'll reach out to this number within 24 hrs